Sök (Nyheter)

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

business health

HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation cAMP–biased GLP–1 receptor agonist. Under...
2026-02-24 05:14:00